Richard Steinhart - 01 Jul 2022 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Role
Director
Signature
/s/ Richard Steinhart
Issuer symbol
ATNM
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
01 Jul 2022, 19:16:03 UTC
Previous filing
17 May 2022
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNM Stock Option (Right to Buy) Award $0 +72,156 $0.000000 72,156 01 Jul 2022 Common Stock 72,156 $4.96 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant.
F2 Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested.